First blood clot death reported by Australia due to AstraZeneca vaccine
On Friday, Australia reported first fatality from blood clots in a person who took the Covid-19 shot. The regulator of the vaccine said that there was a link between the death of the 48-year-old women and the vaccine.
In Australia people were facing blood clots after they administered the vaccine in the country. The woman was the third person to face the blood clot.
Therapeutic Goods Administration (TGA) added that the other two people are recovering well.
It also said that such cases are being carefully reviewed in Australia.
The government in Australia announced on April 8 that the Pfizer vaccine would be given to patients under 50 and the New South Wales woman received the AstraZeneca vaccine on the same day.
The TGA said that the Australia’s Vaccine Safety Investigation Group (VSIG) “believed that a causative link to vaccination should be assumed at this time” as there was no other cause through which the women could get the blood clots.
On Friday, the VSIG held a meeting after the news of the women`s death.
The case of the women had been complicated because of the underlying medical conditions, including diabetes, “as well as some atypical features”, the TGA said.
The TGA said that in every 295,000 cases, a frequency of instance of blood clot was found. At least 885,000 doses of the AstraZeneca vaccines administered in Australia so far.
“The overall number …so far has been no higher than the expected background rate for the more common type of blood clots,” it said.
The UK regulator, the Medicines and Healthcare Products Regulatory Agency, said that 1 in 250,000 reported the overall risk of cerebral venous sinus thrombosis, a rare blood clot in the brain after reviewing the cases reported in the UK.
Australia has reported over 22,000 COVID-19 cases of community transmission and 909 deaths.